Vraylar 1.5 MG capsule 30S
Ended Awarded
- Contract number
- SPE2DB25FAW82
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,126
Award facts
- Contract value 100% obligated
- $14,125.93 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency has awarded a delivery order valued at $14,125.93 to AmerisourceBergen Drug Corp for the supply of Vraylar 1.5 mg capsules (30-count packaging), with a firm fixed price and no set-aside designation. The award was made on May 6, 2025, with an ultimate completion date of May 7, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a routine pharmaceutical procurement under AmerisourceBergen's existing contract vehicle with the DLA.
This award is issued as a child contract under AmerisourceBergen's $999.99 billion Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and running through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. This specific delivery order for Vraylar, a neurological treatment medication, exemplifies the company's role in supplying brand-name and generic medications across multiple therapeutic domains to support Defense Health Agency and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FAW82?
SPE2DB25FAW82 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on May 6, 2025.
How much is contract SPE2DB25FAW82 worth?
The government has obligated $14,126 on SPE2DB25FAW82.
Is contract SPE2DB25FAW82 an order under another contract?
Yes. SPE2DB25FAW82 is a delivery order under SPE2DB22D3009, an indefinite delivery contract.
Was contract SPE2DB25FAW82 competed?
The extent of competition for SPE2DB25FAW82 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award